Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
- PMID: 34867203
- PMCID: PMC8640214
- DOI: 10.3389/fncel.2021.764761
Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
Abstract
Rett syndrome (RTT) and Fragile X syndrome (FXS) are two monogenetic neurodevelopmental disorders with complex clinical presentations. RTT is caused by mutations in the Methyl-CpG binding protein 2 gene (MECP2) altering the function of its protein product MeCP2. MeCP2 modulates gene expression by binding methylated CpG dinucleotides, and by interacting with transcription factors. FXS is caused by the silencing of the FMR1 gene encoding the Fragile X Mental Retardation Protein (FMRP), a RNA binding protein involved in multiple steps of RNA metabolism, and modulating the translation of thousands of proteins including a large set of synaptic proteins. Despite differences in genetic etiology, there are overlapping features in RTT and FXS, possibly due to interactions between MeCP2 and FMRP, and to the regulation of pathways resulting in dysregulation of common molecular signaling. Furthermore, basic physiological mechanisms are regulated by these proteins and might concur to the pathophysiology of both syndromes. Considering that RTT and FXS are disorders affecting brain development, and that most of the common targets of MeCP2 and FMRP are involved in brain activity, we discuss the mechanisms of synaptic function and plasticity altered in RTT and FXS, and we consider the similarities and the differences between these two disorders.
Keywords: FMRP; Fragile X syndrome; MeCP2; Rett syndrome; neurodevelopmental disorders; synaptic plasticity.
Copyright © 2021 Bach, Shovlin, Moriarty, Bardoni and Tropea.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex.Hum Mol Genet. 2021 Feb 4;29(23):3744-3756. doi: 10.1093/hmg/ddaa226. Hum Mol Genet. 2021. PMID: 33084871 Free PMC article.
-
Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome.J Neurosci. 2016 Nov 23;36(47):11946-11958. doi: 10.1523/JNEUROSCI.0672-16.2016. J Neurosci. 2016. PMID: 27881780 Free PMC article.
-
MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.Brain Dev. 2012 Jun;34(6):487-95. doi: 10.1016/j.braindev.2011.09.002. Epub 2011 Oct 6. Brain Dev. 2012. PMID: 21982064
-
Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.Free Radic Biol Med. 2015 Nov;88(Pt A):81-90. doi: 10.1016/j.freeradbiomed.2015.04.019. Epub 2015 May 8. Free Radic Biol Med. 2015. PMID: 25960047 Review.
-
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage.Neuropsychiatr Dis Treat. 2022 Nov 29;18:2813-2835. doi: 10.2147/NDT.S371483. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36471747 Free PMC article. Review.
Cited by
-
The SPOC domain is a phosphoserine binding module that bridges transcription machinery with co- and post-transcriptional regulators.Nat Commun. 2023 Jan 11;14(1):166. doi: 10.1038/s41467-023-35853-1. Nat Commun. 2023. PMID: 36631525 Free PMC article.
-
Neuroimmune mechanisms in autism etiology - untangling a complex problem using human cellular models.Oxf Open Neurosci. 2024 Feb 22;3:kvae003. doi: 10.1093/oons/kvae003. eCollection 2024. Oxf Open Neurosci. 2024. PMID: 38665176 Free PMC article.
-
Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids.Res Sq [Preprint]. 2023 Sep 28:rs.3.rs-3270664. doi: 10.21203/rs.3.rs-3270664/v1. Res Sq. 2023. Update in: Mol Psychiatry. 2024 Aug;29(8):2424-2437. doi: 10.1038/s41380-024-02518-4 PMID: 37841865 Free PMC article. Updated. Preprint.
-
Altered Purinergic Signaling in Neurodevelopmental Disorders: Focus on P2 Receptors.Biomolecules. 2023 May 18;13(5):856. doi: 10.3390/biom13050856. Biomolecules. 2023. PMID: 37238724 Free PMC article. Review.
-
Haploinsufficiency of Shank3 increases the orientation selectivity of V1 neurons.Sci Rep. 2022 Dec 23;12(1):22230. doi: 10.1038/s41598-022-26402-9. Sci Rep. 2022. PMID: 36564435 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources